Research on the application of octacalcium phosphate/collagen composite to carry low-dose recombinant human bone morphogenetic protein-2 in bone regeneration

  • Nguyễn Điện Biên Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

octacalcium phosphate, rhBMP-2, bone regeneration, octacalcium phosphate recombinant human bone morphogenetic protein 2

Abstract

Objective: To evaluate the effective use of octacalcium phoshate/collagen (OCP/Col) as a carrier to reduce the concentration of recombinant human bone morphogenetic protein 2 (rhBMP-2) but still be effective. Subject and method: A cross-sectional descriptive experimental study with comparative control. Atelocollagen-ACS or OCP/Col sponge discs were impregnated with different concentrations of rhBMP-2 and implanted in 60 mice with calvarial bone defects. The transplanted tissue was obtained after 4, 6 weeks. Result: There was perform hard tissue formation in the defects of the OCP/Col groups at all concentrations of rhBMP-2. The ACS group had 0.25μg of rhBMP-2 showed almost no bone formation. Bone mineral density in all groups was independent of rhBMP-2 concentration. Progressive bone formation was dependent on rhBMP-2 concentration in both groups. The new bone area was significantly more in the OCP/Col groups than in the ACS groups. Conclusion: OCP/Col can be a carrier of rhBMP-2, reducing the effective dose of rhBMP-2 by up to 1/4, avoiding complications caused by rhBMP-2 at high doses.

Article Details

References

1. Boerckel JD, Kolambkar YM et al (2011) Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 32: 5241-5251.
2. Brown KV, Li B et al (2011) Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. Tissue Eng Part A 17: 1735-1746.
3. Carreira A, Lojudice F et al (2014) Bone morphogenetic proteins: Facts, challenges, and future perspectives. J Dent Res 93: 335-345.
4. Kamakura S, Sasano Y et al (2002) Implanted octacalcium phosphate is more resorbable than β‐ tricalcium phosphate and hydroxyapatite. J Biomed Mater Res Part A 59: 29-34.
5. Kawai T, Tanuma Y et al (2016) Clinical safety and efficacy of implantation of octacalcium phosphate collagen composites in tooth extraction sockets and cyst holes. J Tissue Eng 7: 2041731416670770.
6. Kouketsu A, Matsui K et al (2020) Octacalcium phosphate collagen composite stimulates the expression and activity of osteogenic factors to promote bone regeneration. J Tissue Eng Regen Med 14: 99-107. 

7. Lee YH, Lee BW et al (2019) Application of alginate microbeads as a carrier of bone morphogenetic protein-2 for bone regeneration. J Biomed Mater Res B Appl Biomater 107: 286-294.
8. Lichte P, Pape HC et al (2011) Scaffolds for bone healing: Concepts, materials and evidence. Injury 42: 569-573.
9. Suzuki O, Kamakura S et al (2006) Bone formation enhanced by implanted octacalcium phosphate involving conversion into Ca-deficient hydroxyapatite. Biomaterials 27: 2671-2681.
10. Woo EJ (2012) Adverse events reported after the use of recombinant human bone morphogenetic protein 2. J Oral Maxillofac Surg 70: 765-767.